Literature DB >> 20697023

Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.

Jiusong Sun1, Karsten Hartvigsen, Meng-Yun Chou, Yadong Zhang, Galina K Sukhova, Jie Zhang, Marco Lopez-Ilasaca, Cody J Diehl, Niva Yakov, Dror Harats, Jacob George, Joseph L Witztum, Peter Libby, Hidde Ploegh, Guo-Ping Shi.   

Abstract

BACKGROUND: Adaptive immunity and innate immunity play important roles in atherogenesis. Invariant chain (CD74) mediates antigen-presenting cell antigen presentation and T-cell activation. This study tested the hypothesis that CD74-deficient mice have reduced numbers of active T cells and resist atherogenesis. METHODS AND
RESULTS: In low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice, CD74 deficiency (Ldlr(-/-)Cd74(-/-)) significantly reduced atherosclerosis and CD25(+)-activated T cells in the atheromata. Although Ldlr(-/-)Cd74(-/-) mice had decreased levels of plasma immunoglobulin (Ig) G1, IgG2b, and IgG2c against malondialdehyde-modified LDL (MDA-LDL), presumably as a result of impaired antigen-presenting cell function, Ldlr(-/-)Cd74(-/-) mice showed higher levels of anti-MDA-LDL IgM and IgG3. After immunization with MDA-LDL, Ldlr(-/-)Cd74(-/-) mice had lower levels of all anti-MDA-LDL Ig isotypes compared with Ldlr(-/-) mice. As anticipated, only Ldlr(-/-) splenocytes responded to in vitro stimulation with MDA-LDL, producing Th1/Th2 cytokines. Heat shock protein-65 immunization enhanced atherogenesis in Ldlr(-/-) mice, but Ldlr(-/-) Cd74(-/-) mice remained protected. Compared with Ldlr(-/-) mice, Ldlr(-/-)Cd74(-/-) mice had higher anti-MDA-LDL autoantibody titers, fewer lesion CD25(+)-activated T cells, impaired release of Th1/Th2 cytokines from antigen-presenting cells after heat shock protein-65 stimulation, and reduced levels of all plasma anti-heat shock protein-65 Ig isotypes. Cytofluorimetry of splenocytes and peritoneal cavity cells of MDA-LDL- or heat shock protein-65-immunized mice showed increased percentages of autoantibody-producing marginal zone B and B-1 cells in Ldlr(-/-)Cd74(-/-) mice compared with Ldlr(-/-) mice.
CONCLUSIONS: Invariant chain deficiency in Ldlr(-/-) mice reduced atherosclerosis. This finding was associated with an impaired adaptive immune response to disease-specific antigens. Concomitantly, an unexpected increase in the number of innate-like peripheral B-1 cell populations occurred, resulting in increased IgM/IgG3 titers to the oxidation-specific epitopes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697023      PMCID: PMC2927799          DOI: 10.1161/CIRCULATIONAHA.109.891887

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

1.  Cathepsin S required for normal MHC class II peptide loading and germinal center development.

Authors:  G P Shi; J A Villadangos; G Dranoff; C Small; L Gu; K J Haley; R Riese; H L Ploegh; H A Chapman
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

Review 2.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

3.  Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway.

Authors:  Michal Cohen-Sfady; Gabriel Nussbaum; Meirav Pevsner-Fischer; Felix Mor; Pnina Carmi; Alexandra Zanin-Zhorov; Ofer Lider; Irun R Cohen
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

4.  BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge.

Authors:  G Kenty; E K Bikoff
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 5.  Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.

Authors:  Anna Abou-Raya; Suzan Abou-Raya
Journal:  Autoimmun Rev       Date:  2006-02-03       Impact factor: 9.754

6.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

Authors:  J Frostegård; A K Ulfgren; P Nyberg; U Hedin; J Swedenborg; U Andersson; G K Hansson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

7.  Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.

Authors:  Xinghua Zhou; Anna-Karin L Robertson; Charlotta Hjerpe; Göran K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-02       Impact factor: 8.311

8.  Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.

Authors:  Jose R Faria-Neto; Kuang-Yuh Chyu; Xiaojun Li; Paul C Dimayuga; Carmel Ferreira; Juliana Yano; Bojan Cercek; Prediman K Shah
Journal:  Atherosclerosis       Date:  2006-01-18       Impact factor: 5.162

9.  Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques.

Authors:  Marisa Benagiano; Mario M D'Elios; Amedeo Amedei; Annalisa Azzurri; Ruurd van der Zee; Alessandra Ciervo; Gianni Rombolà; Sergio Romagnani; Antonio Cassone; Gianfranco Del Prete
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

10.  Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.

Authors:  S Freigang; S Hörkkö; E Miller; J L Witztum; W Palinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-12       Impact factor: 8.311

View more
  39 in total

Review 1.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

Review 2.  How dendritic cells shape atherosclerosis.

Authors:  Ekaterina K Koltsova; Klaus Ley
Journal:  Trends Immunol       Date:  2011-08-10       Impact factor: 16.687

Review 3.  How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.

Authors:  Jillian P Rhoads; Amy S Major
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 4.  Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Authors:  Andrew H Lichtman; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 5.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

6.  Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.

Authors:  Corinna Schmitz; Heidi Noels; Omar El Bounkari; Eva Straussfeld; Remco T A Megens; Marieke Sternkopf; Setareh Alampour-Rajabi; Christine Krammer; Pathricia V Tilstam; Norbert Gerdes; Christina Bürger; Aphrodite Kapurniotu; Richard Bucala; Joachim Jankowski; Christian Weber; Jürgen Bernhagen
Journal:  FASEB J       Date:  2018-03-15       Impact factor: 5.191

7.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 9.  Tolerization against atherosclerosis using heat shock protein 60.

Authors:  Cecilia Wick
Journal:  Cell Stress Chaperones       Date:  2015-11-17       Impact factor: 3.667

Review 10.  Dendritic cells in atherosclerosis.

Authors:  Manikandan Subramanian; Ira Tabas
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.